DrugRisk Alerts of Increase in Pradaxa Lawsuits Alleging Internal Bleeding
The DrugRisk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com
Chicago, IL (PRWEB) July 11, 2013
The prescription drug safety advocates at DrugRisk.com are announcing new information for patients taking the blood thinner Pradaxa. A federal panel reports lawsuits alleging internal bleeding have grown in recent months*.
DrugRisk was created to improve the safety of patients taking popular prescription drugs like Pradaxa by sharing the latest warnings, recalls, studies and legal news. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.
Pradaxa was launched in 2010 to prevent strokes in patients with atrial fibrillation. Experts disagree, however, about whether it carries higher risks for internal bleeding. The FDA has advised that Pradaxa is no more dangerous than traditional blood thinner warfarin**.
However, the Institute for Safe Medication Practices warned that patients suffering Pradaxa bleeding are nearly 5 times as likely to die than those with bleeding from warfarin***. A University of Illinois study suggested the FDA information may be flawed, and Pradaxa bleeding risks may be higher than expected****. Also, a recent Danish study concluded patients’ risks of internal bleeding may rise when switching from other blood thinners to Pradaxa*****.
A growing number of patients have filed a Pradaxa lawsuit alleging internal bleeding, with cases now being consolidated to a special federal court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.
Now, DrugRisk has learned that the latest report from the Judicial Panel on Multidistrict Litigation shows the number of cases filed in the federal MDL court has nearly doubled, from 663 on May 15th to 1,133 on July 10*.
Anyone affected by internal bleeding after taking Pradaxa is encouraged to visit DrugRisk.com or speak with a lawyer about their legal options. However, DrugRisk only recommends lawyers who have already handled federal drug injury cases like Pradaxa lawsuits.
For more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.
*JPML 7/10/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-July-10-2013.pdf
**FDA, 11/2/12; http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm
***Institute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
****New England Journal of Medicine, 4/4/13; nejm.org/doi/full/10.1056/NEJMp1302834
*****British Medical Journal, 5/3/13; bmjopen.bmj.com/content/3/5/e002758.long
For the original version on PRWeb visit: http://www.prweb.com/releases/pradaxa-internal-bleeding/lawsuit-alert/prweb10918631.htm